Immunoprophylaxis and serotherapy of bacterial infections
- 1 April 1984
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (4) , 664-671
- https://doi.org/10.1016/0002-9343(84)90292-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.Journal of Clinical Investigation, 1982
- CONTROLLED TRIALS OF A POLYVALENT PSEUDOMONAS VACCINE IN BURNSThe Lancet, 1979
- A New Polyvalent Pseudomonas VaccineJournal of Medical Microbiology, 1977
- Use of a Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosisThe American Journal of Medicine, 1975
- Pseudomonas aeruginosa Vaccine in Cancer PatientsAnnals of Internal Medicine, 1973
- Controlled prospective trial ofPseudomonas aeruginosa vaccine in children with acute leukemiaCancer, 1973
- Infectious Complications of Neoplastic DiseaseMedical Clinics of North America, 1971
- Immunological Control of Pseudomonas Infection in Burn Patients: A Clinical EvaluationArchives of Surgery, 1971
- A Reduction of Pseudomonas Septicemias in Burned Patients By the Immune ProcessSurgical Clinics of North America, 1970
- ACTIVE IMMUNOPROPHYLAXIS IN BURNS WITH A NEW MULTIVALENT VACCINEThe Lancet, 1970